Information Provided By:
Fly News Breaks for October 8, 2018
BDSI
Oct 8, 2018 | 07:11 EDT
H.C. Wainwright analyst Oren Livnat raised his price target for BioDelivery Sciences to $5 citing the company's "upbeat" analyst day. All indications are that with continued commercial and managed care execution, Belbuca will continue to gain market share, Livnat tells investors in a research note. He sees management's projected $200M potential as achievable and keeps a Buy rating on the shares.
News For BDSI From the Last 2 Days
There are no results for your query BDSI